Anderley Gordon
Royal Marsden Hospital · 46 works · 1,632 citations · h-index 10
Top works
- Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
- Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
- Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study
- Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.
- A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK
- Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysis
- Transvaginal sonography of postmenopausal ovaries with pathologic correlation.
- Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting.
- Sigmoidovaginal fistula secondary to diverticular disease. A report of three cases.
- Phase I study of topotecan (T) with carboplatin (C) alternating with paclitaxel (P) via 3 hour infusion with carboplatin (C) in treatment of newly diagnosed ovarian cancer (OC)
- Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
- Is pathological response an adequate surrogate marker for survival in neoadjuvant therapy with immune checkpoint inhibitors?
- Clinical Outcomes and Assessment of Racial Disparities for Vulvar Squamous Cell Carcinoma Treated With Radiotherapy
- Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Interim analysis of induction chemotherapy
- Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Final safety and efficacy report.
- Phase Ib study of AMG 386 combined with either pegylated liposomal doxorubicin (PLD) or topotecan (T) in patients with advanced ovarian cancer.
- 91008743 Transvaginal sonography of postmenopausal ovaries with pathologic correlation
- Abstract 5591: Circulating tumor DNA for recurrence prediction and efficacy analysis in the ICONIC trial of peri-operative FLOT and avelumab (PD-L1) in localized esophago-gastric adenocarcinoma
- Primary results of the ICONIC phase 2 trial of perioperative FLOT plus avelumab (FLOT-A) in operable oesophagogastric adenocarcinoma (OGA).
- Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma